201 related articles for article (PubMed ID: 29486328)
1. Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma.
Mendes M; Miranda A; Cova T; Gonçalves L; Almeida AJ; Sousa JJ; do Vale MLC; Marques EF; Pais A; Vitorino C
Eur J Pharm Sci; 2018 May; 117():255-269. PubMed ID: 29486328
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
4. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
7. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
9. Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier.
Sun M; Zhu Z; Wang H; Han C; Liu D; Tian L; Yang X; Pan W
Drug Deliv; 2017 Nov; 24(1):519-526. PubMed ID: 28181841
[TBL] [Abstract][Full Text] [Related]
10. Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: A computationally guided experimental approach.
Mendes M; Basso J; Silva J; Cova T; Sousa J; Pais A; Vitorino C
Int J Pharm; 2020 Sep; 587():119661. PubMed ID: 32693289
[TBL] [Abstract][Full Text] [Related]
11. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
Song S; Mao G; Du J; Zhu X
Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
Di Filippo LD; Lobato Duarte J; Hofstätter Azambuja J; Isler Mancuso R; Tavares Luiz M; Hugo Sousa Araújo V; Delbone Figueiredo I; Barretto-de-Souza L; Miguel Sábio R; Sasso-Cerri E; Martins Baviera A; Crestani CC; Teresinha Ollala Saad S; Chorilli M
Int J Pharm; 2022 Apr; 618():121682. PubMed ID: 35307470
[TBL] [Abstract][Full Text] [Related]
13. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.
Grillone A; Battaglini M; Moscato S; Mattii L; de Julián Fernández C; Scarpellini A; Giorgi M; Sinibaldi E; Ciofani G
Nanomedicine (Lond); 2019 Mar; 14(6):727-752. PubMed ID: 30574827
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
[TBL] [Abstract][Full Text] [Related]
16. Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook.
Sabir F; Ismail R; Csoka I
Drug Discov Today; 2020 Jan; 25(1):185-194. PubMed ID: 31629966
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
18. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
19. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
20. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
